These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22659580)

  • 1. The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis.
    Philbert J; Pichat P; Palme R; Belzung C; Griebel G
    Pharmacol Biochem Behav; 2012 Sep; 102(3):415-22. PubMed ID: 22659580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine.
    Philbert J; Belzung C; Griebel G
    Psychopharmacology (Berl); 2013 Jul; 228(1):97-107. PubMed ID: 23407783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
    Philbert J; Beeské S; Belzung C; Griebel G
    Behav Brain Res; 2015 Feb; 279():41-6. PubMed ID: 25446760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
    Urani A; Philbert J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamus-pituitary-adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats.
    Raone A; Cassanelli A; Scheggi S; Rauggi R; Danielli B; De Montis MG
    Neuroscience; 2007 Jun; 146(4):1734-42. PubMed ID: 17481824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus-pituitary-adrenal axis reactivity in mice with mild traumatic brain injury.
    Kosari-Nasab M; Sadeghi T; Bashiri H; Shokouhi G; Salari AA
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):220-228. PubMed ID: 30883392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of early adolescent stress: dysregulation of hypothalamic-pituitary-adrenal axis and central corticotropin releasing factor receptor 1 expression in adult male rats.
    Li C; Liu Y; Yin S; Lu C; Liu D; Jiang H; Pan F
    Behav Brain Res; 2015 Jul; 288():39-49. PubMed ID: 25882722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
    Louis C; Cohen C; Depoortère R; Griebel G
    Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice.
    Jiang X; Wang J; Luo T; Li Q
    Psychoneuroendocrinology; 2009 Apr; 34(3):317-31. PubMed ID: 18980809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
    Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
    Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats.
    Jensen JB; Jessop DS; Harbuz MS; Mørk A; Sánchez C; Mikkelsen JD
    J Neuroendocrinol; 1999 Jun; 11(6):465-71. PubMed ID: 10336728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.
    Flandreau EI; Bourke CH; Ressler KJ; Vale WW; Nemeroff CB; Owens MJ
    Psychoneuroendocrinology; 2013 Aug; 38(8):1349-61. PubMed ID: 23267723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms mediating the influence of alcohol on the hypothalamic-pituitary-adrenal axis responses to immune and nonimmune signals.
    Ogilvie K; Lee S; Weiss B; Rivier C
    Alcohol Clin Exp Res; 1998 Aug; 22(5 Suppl):243S-247S. PubMed ID: 9727644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Stress-Induced ACTH Secretion by Vasopressin and CRH: Additional Evidence.
    Ramos AT; Tufik S; Troncone LR
    Neuropsychobiology; 2016; 73(3):184-90. PubMed ID: 27221315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic maternal dexamethasone treatment on the hormones of the hypothalamo-pituitary-adrenal axis in the rat fetus.
    Dupouy JP; Chatelain A; Boudouresque F; Conte-Devolx B; Oliver C
    Biol Neonate; 1987; 52(4):216-22. PubMed ID: 2823915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.